跳至主要内容
临床试验/NCT03505567
NCT03505567已完成不适用

Pilot Comparative Study of the Kowa OCT Bi-μ and the Optovue iVue 100

Kowa Research Institute, Inc.2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2018年4月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
2
主要终点
Compare KOWA OCT Bi-μ and Optovue iVue 100

研究概览

简要总结

This study is a prospective comparative study to gather pilot agreement and precision data in normal subjects, subjects with glaucoma, and subjects with retinal disease.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Random Sequenced Interventions

Other

Participants from three condition groups (normal, glaucoma, retinal disease) assigned two interventions (Kowa OCT Bi-μ and the Optovue iVue 100) under random sequence assignments.

干预措施: KOWA OCT Bi-µ (Device)

Random Sequenced Interventions

Other

Participants from three condition groups (normal, glaucoma, retinal disease) assigned two interventions (Kowa OCT Bi-μ and the Optovue iVue 100) under random sequence assignments.

干预措施: Optovue iVue 100 (Device)

结局指标

主要结局

Compare KOWA OCT Bi-μ and Optovue iVue 100

时间窗: 1-2 days

1. Full retinal thickness \[Early Treatment Diabetic Retinopathy Study (ETDRS) Grid\] 2. Full retinal thickness (Manual Measurement) 3. Retinal nerve fiber layer thickness 4. Ganglion cell complex thickness 5. Full retinal thickness map

次要结局

  • Safety: Evaluate any adverse events found during the clinical study(1-2 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验